<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report" xml:lang="en">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
      <journal-title-group>
        <journal-title>BMC Medical Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2350</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23849371</article-id>
      <article-id pub-id-type="pmc">3722009</article-id>
      <article-id pub-id-type="publisher-id">1471-2350-14-70</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2350-14-70</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Dystonia, facial dysmorphism, intellectual disability and breast cancer associated with a chromosome 13q34 duplication and overexpression of <italic>TFDP1</italic>: case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Moscovich</surname>
            <given-names>Mariana</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>marimoscovich@hotmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>LeDoux</surname>
            <given-names>Mark S</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>mledoux@uthsc.edu</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Xiao</surname>
            <given-names>Jianfeng</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>jianfengxiao@gmail.com</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Rampon</surname>
            <given-names>Garrett L</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>grampon@uthsc.edu</email>
        </contrib>
        <contrib contrib-type="author" id="A5">
          <name>
            <surname>Vemula</surname>
            <given-names>Satya R</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>svemula@uthsc.edu</email>
        </contrib>
        <contrib contrib-type="author" id="A6">
          <name>
            <surname>Rodriguez</surname>
            <given-names>Ramon L</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>ramon.rodriguez@neurology.ufl.edu</email>
        </contrib>
        <contrib contrib-type="author" id="A7">
          <name>
            <surname>Foote</surname>
            <given-names>Kelly D</given-names>
          </name>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>foote@neurosurgery.ufl.edu</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A8">
          <name>
            <surname>Okun</surname>
            <given-names>Michael S</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>okun@neurology.ufl.edu</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Center for Movement Disorders and Neurorestoration, Department of Neurology, University of Florida College of Medicine, 100 S Newell Drive, Room L3-101, Gainesville, FL 32610, USA</aff>
      <aff id="I2"><label>2</label>Department of Neurology, University of Tennessee Health Science Center, 855 Monroe Avenue, Suite 415 Link Building, Memphis, Tennessee 38163, USA</aff>
      <aff id="I3"><label>3</label>Center for Movement Disorders &amp; Neurorestoration, Department of Neurosurgery, University of Florida, McKnight Brain Institute, 100 S Newell Drive, Room L2-100, Gainesville, FL 32610, USA</aff>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>7</month>
        <year>2013</year>
      </pub-date>
      <volume>14</volume>
      <fpage>70</fpage>
      <lpage>70</lpage>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>7</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2013 Moscovich et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Moscovich et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1471-2350/14/70"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Dystonia is a movement disorder characterized by involuntary sustained muscle contractions causing twisting and repetitive movements or abnormal postures. Some cases of primary and neurodegenerative dystonia have been associated with mutations in individual genes critical to the G<sub>1</sub>-S checkpoint pathway (<italic>THAP1</italic>, <italic>ATM</italic>, <italic>CIZ1</italic> and <italic>TAF1</italic>). Secondary dystonia is also a relatively common clinical sign in many neurogenetic disorders. However, the contribution of structural variation in the genome to the etiopathogenesis of dystonia remains largely unexplored.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>Cytogenetic analyses with the Affymetrix Genome-Wide Human SNP Array 6.0 identified a chromosome 13q34 duplication in a 36&#xA0;year-old female with global developmental delay, facial dysmorphism, tall stature, breast cancer and dystonia, and her neurologically-normal father. Dystonia improved with bilateral globus pallidus interna (GPi) deep brain stimulation (DBS). Genomic breakpoint analysis, quantitative PCR (qPCR) and leukocyte gene expression were used to characterize the structural variant. The 218,345&#xA0;bp duplication was found to include <italic>ADPRHL1</italic>, <italic>DCUN1D2</italic>, and <italic>TMCO3</italic>, and a 69&#xA0;bp fragment from a long terminal repeat (LTR) located within Intron 3 of <italic>TFDP1</italic>. The 3<italic>'</italic> breakpoint was located within Exon 1 of a <italic>TFDP1</italic> long non-coding RNA (NR_026580.1). In the affected subject and her father, gene expression was higher for all three genes located within the duplication. However, in comparison to her father, mother and neurologically-normal controls, the affected subject also showed marked overexpression (2&#xD7;) of the transcription factor <italic>TFDP1</italic> (NM_007111.4). Whole-exome sequencing identified an <italic>SGCE</italic> variant (c.1295G&#x2009;&gt;&#x2009;A, p.Ser432His) that could possibly have contributed to the development of dystonia in the proband. No pathogenic mutations were identified in <italic>BRCA1</italic> or <italic>BRCA2</italic>.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Overexpression of <italic>TFDP1</italic> has been associated with breast cancer and may also be linked to the tall stature, dysmorphism and dystonia seen in our patient.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Dystonia</kwd>
        <kwd>Chromosome 13q34</kwd>
        <kwd>Duplication</kwd>
        <kwd>
          <italic>TFDP1</italic>
        </kwd>
        <kwd>Breast cancer</kwd>
        <kwd>G<sub>1</sub>-S Checkpoint pathway</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Chromosome 13q34 amplifications have been reported in lung cancer [<xref ref-type="bibr" rid="B1">1</xref>], small bowel adenocarcinoma [<xref ref-type="bibr" rid="B2">2</xref>], hepatocellular carcinoma [<xref ref-type="bibr" rid="B3">3</xref>], squamous cell carcinoma of the esophagus [<xref ref-type="bibr" rid="B4">4</xref>], and breast cancer [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Overexpression of genes in this region, particularly <italic>TFDP1</italic>, may be causally associated with the development or progression of these malignancies [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. <italic>TFDP1</italic> encodes the transcription factor DP-1. DP-1 forms heterodimers with E2F family members to enhance their DNA-binding and promote transcription of E2F target genes. The E2F/DP-1 complex plays a critical role in the G<sub>1</sub>-S cell-cycle transition [<xref ref-type="bibr" rid="B7">7</xref>].</p>
      <p>Numerous stimuli, including DNA damage, TGF&#x3B2;, replicative senescence, and contact inhibition, exert control over the G<sub>1</sub>-S checkpoint pathway [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. Defects in this pathway have been associated with developmental defects, neurodegenerative disorders, cancer and dystonia [<xref ref-type="bibr" rid="B10">10</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. In particular, five genes linked to dystonia appear to be involved upstream or downstream of DP-1 in the G<sub>1</sub>-S checkpoint pathway (<italic>ATM</italic>, <italic>CIZ1</italic>, <italic>TOR1A</italic>, <italic>THAP1</italic> and <italic>TAF1</italic>). Autosomal recessive mutations of <italic>ATM</italic> increase risk for malignancies and typically present as ataxia telangiectasia. However, some patients present with isolated dystonia [<xref ref-type="bibr" rid="B11">11</xref>]. Moreover, female carriers are at higher risk for breast cancer [<xref ref-type="bibr" rid="B13">13</xref>]. The encoded protein, ataxia telangiectasia mutated (ATM), activates p53 by phosphorylating the ubiquitin E3 ligase MDM2 [<xref ref-type="bibr" rid="B14">14</xref>]. Reduced neuronal expression of <italic>TAF1</italic> is linked to a form of dystonia-parkinsonism known as Lubag or DYT3 [<xref ref-type="bibr" rid="B15">15</xref>]. TAF1 mediates degradation of p53 via phosphorylation at Thr-55 [<xref ref-type="bibr" rid="B16">16</xref>]. CIZ1 interacts with p21Cip1 [<xref ref-type="bibr" rid="B17">17</xref>]. TorsinA, the protein encoded by <italic>TOR1A</italic>, interferes with TGF&#x3B2; signaling pathway [<xref ref-type="bibr" rid="B18">18</xref>]. Finally, the S-phase gene <italic>RRM1</italic> is a direct transcriptional target of THAP1 [<xref ref-type="bibr" rid="B19">19</xref>].</p>
      <p>Herein, we report a unique patient with a chromosome 13q34 duplication, dystonia, dysmorphism, intellectual disability, psychosis, tall stature, and breast cancer. Gene expression studies suggest that one or more of these phenotypic features may be due to overexpression of <italic>TFDP1</italic>.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>A 36&#xA0;year-old right-handed Hispanic woman presented for evaluation of stiffness, painful muscle spasms, difficulty walking, falling, and abnormal involuntary hyperkinetic movements that had progressed over three years. She also reported decreased motivation, speech articulation problems, and difficulty with all activities of daily living as well as with handwriting. The chronology of proband&#x2019;s signs and symptoms is outlined in Table&#xA0;<xref ref-type="table" rid="T1">1</xref>.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Chronology of proband&#x2019;s signs and symptoms</p>
        </caption>
        <table frame="hsides" rules="groups" border="1">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead valign="top">
            <tr>
              <th align="left">&#xA0;</th>
              <th align="left">&#xA0;</th>
            </tr>
          </thead>
          <tbody valign="top">
            <tr>
              <td align="left" valign="bottom">1976<hr/></td>
              <td align="left" valign="bottom">Born by cesarean section at full term.<hr/></td>
            </tr>
            <tr>
              <td rowspan="3" align="left" valign="top">1976-1986<hr/></td>
              <td align="left" valign="bottom">Did not sit until after 6&#xA0;months of age and did not walk until 18&#xA0;months of age.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Enrolled in special education classes in the first grade.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Developmental delay, Marfanoid features, dysmorphic features, strabismus, mitral valve prolapse were described by pediatrician.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">2003-2007<hr/></td>
              <td align="left" valign="bottom">Appearance of psychiatric symptoms including psychosis treated with valproic acid, risperidone and buproprion.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">2008<hr/></td>
              <td align="left" valign="bottom">Movement disorder becomes manifest (choreoathetotic and dystonic movements in the left arm along with &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;blepharospasm) and is treated with levetiracetam, carbamazepine, oxcarbazepine, lorazepam, biperiden, haloperidol, &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;aripiprazole, topiramate, chlorpromazine, carbidopa/levodopa, baclofen, amantadine, trihexyphenidyl, botulinum toxin &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;injections, and tetrabenazine.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">2009<hr/></td>
              <td align="left" valign="bottom">Despite medical treatment and discontinuation of dopamine blocking drugs, neurological condition progressively worsens &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;with hyperkinetic movements appearing in the right arm and trunk.<hr/></td>
            </tr>
            <tr>
              <td rowspan="6" align="left" valign="top">2010<hr/></td>
              <td align="left" valign="bottom">Mucinous carcinoma of the right breast diagnosed and treated with a modified radical mastectomy with skin preservation &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;and immediate reconstruction with breast prosthesis.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Histology report shows no residual tumor at tissue margins and lymph nodes free of tumor.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Post-operative treatment with tamoxifen.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Worsening of the dystonia with appearance of truncal dystonia including painful retrocollis.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Difficulty staying upright for even short periods.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Weight loss of 25 pounds.<hr/></td>
            </tr>
            <tr>
              <td rowspan="5" align="left" valign="top">2011<hr/></td>
              <td align="left" valign="bottom">Implantation of bilateral globus pallidus internus electrodes for deep brain stimulation.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Marked improvement of dystonia 4&#xA0;months after surgery.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Subject able to feed herself, sit upright and walk.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Significant improvements in neck pain.<hr/></td>
            </tr>
            <tr>
              <td align="left" valign="bottom">Revision of left and right pulse generators, and replacement of left extension cable after lead fracture due to twiddler &#xA0;&#xA0;&#xA0;&#xA0;&#xA0;syndrome (obsessively moving the generators in the chest leading to device fracture).<hr/></td>
            </tr>
            <tr>
              <td align="left">2013</td>
              <td align="left">Facial dystonia markedly improved. Sustained control of dystonia with deep brain stimulation.</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>She was born by cesarean section and was noted to be hypoxemic but was delivered at full term. She was the fourth child in her family, and none of the other children had neurological disorders or cancer related illnesses. Her motor and cognitive development was delayed. She did not sit until after 6&#xA0;months of age and did not walk until 18&#xA0;months of age, and was enrolled in special education classes in the first grade.</p>
      <p>Because of her tall stature at 7&#xA0;years of age, a diagnosis of Marfan syndrome was suggested by her physicians but never confirmed with molecular genetic testing. She completed a total of 6&#xA0;years of schooling. At 30&#xA0;years of age, she developed a psychiatric disturbance with psychotic features. She became obsessed with popular rock and roll bands and experienced visual and auditory hallucinations. She was briefly hospitalized for psychosis, and was treated successfully for three years with risperidone (1&#xA0;mg three times daily), valproic acid and buproprion. However, she then began to manifest what was described as choreoathetotic and dystonic movements in her left arm along with blepharospasm. She was treated with levetiracetam, carbamazepine, oxcarbamazepine, clonazepam, biperidone, haldoperidol, aripiprazole, topiramate, baclofen, carbidopa/levodopa, chlorpromazine, amantadine, trihexyphenidyl, and botulinum toxin injections. These medical treatments were only mildly beneficial, and her neurological condition progressively worsened with the appearance of hyperkinetic movements affecting her right arm and trunk.</p>
      <p>At age 35, she was diagnosed with breast cancer during a routine physical examination. She underwent a radical right mastectomy with preservation of the areola and nipple. Serum prolactin levels were not obtained. She was treated with tamoxifen, post-operatively, and has shown no evidence of local recurrence or metastasis of her breast cancer. Pathology revealed an encapsulated mucinous carcinoma, grade I. The tumor cells inside mucous lakes expressed estrogen and progesterone receptors and did not over-express Her2/neu.</p>
      <p>Her hyperkinetic movement disorder showed an initial modest response to tetrabenazine. However, dystonia gradually worsened with painful retrocollis and truncal dystonia. Over a period of 6&#xA0;months, she lost 25 pounds and became profoundly debilitated by dystonia, spending most of her waking day lying face down.</p>
      <p>Brain magnetic resonance image (MRI) was unremarkable and routine laboratory testing including a comprehensive metabolic profile was normal. A 24-hour urine copper for Wilson&#x2019;s disease was also normal. A 99mTc-HMPAO single photon emission computed tomography (SPECT) showed asymmetric and decreased radiotracer uptake in basal ganglia regions including the caudate, putamen, and globus pallidus. Molecular cytogenetic analysis exposed a chromosome 13q34 duplication.</p>
      <p>At age 36, general physical examination revealed facial dysmorphism with hypertelorism, down slanting palpebral fissures, mild ptosis and large low-set ears with mild posterior rotation (Figure&#xA0;<xref ref-type="fig" rid="F1">1</xref>). Other clinical features included hirsutism, low anterior hairline, micrognathia, brevicollis, scoliosis, arachnodactyly, tall stature (182.9&#xA0;cm), and a weight of 62.3&#xA0;kg (body mass index&#x2009;=&#x2009;18.6). On neurological examination, she was moderately inattentive. No primitive reflexes were noted. She scored a 19/30 on the Montreal Cognitive Assessment (MoCA). MoCA scores of 26 and higher are considered normal. Although cranial nerves were all normal, speech was mildly dysarthric, and facial dystonia was overt. Muscle strength testing was normal. There was no focal atrophy or fasciculations. There was no obvious upper extremity ataxia although testing of coordination was limited by the presence of dystonia. Gait was broad-based and ataxic, and she required assistance to walk. Walking was also compromised by dystonic posturing of her trunk and arms. Sensory testing was normal. Cervical dystonia was manifest as severe retrocollis. Truncal and bilateral arm dystonia had a clear action component and worsened during movement, particularly walking. No contractures were present in the arms or legs. A score of 37 was recorded for the pre-operative Unified Dystonia Rating Scale (UDRS, maximum score is 112).</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Frontal (A) and lateral (B) photographs 4&#xA0;months after GPi DBS show the presence of mild facial dystonia and dysmorphic features. C)</bold> Arachnodactyl and hirsutism. <bold>D)</bold> Virtual resolution of facial dystonia 2&#xA0;yrs after GPi DBS.</p>
        </caption>
        <graphic xlink:href="1471-2350-14-70-1"/>
      </fig>
      <p>The proband underwent bilateral globus pallidus internus (GPi) deep brain stimulation (DBS). She gradually improved and after 4&#xA0;months her facial dystonia was markedly better and she became able to feed herself. She could sit upright and tolerated sitting for progressively longer periods of time. Both subjective and objective improvements in postural stability, gait, and retrocollis were noted. Neck pain and upper limb dystonia were significantly improved. The 4-month post-operative score on the UDRS was 23. However, shortly after this period of clinical improvement, she experienced hardware malfunction due to lead wire fractures caused by her twiddling the implantable pulse generators (IPGs). The lead connectors were replaced and the IPGs tacked down to prevent twiddling, and her dystonia improved once again. Her outpatient clinical course has been compromised by dysphagia and hospitalizations for treatment of aspiration pneumonia which ultimately required placement of a percutaneous endoscopic gastrostomy (PEG) tube.</p>
      <p>The proband&#x2019;s parents and two brothers were neurologically normal and showed no dysmorphic features. Her mother and father were 167.6 and 170.2&#xA0;cm tall, respectively. There was no history of dystonia or breast cancer in any first or second degree relative.</p>
      <p>All human studies were performed in accordance with institutional review board guidelines and the Helsinki Declaration. Written informed consent for genetic studies and publication of clinical data was obtained from the patient, her parents and neurologically-normal controls. All genetic analyses were approved by the University of Tennessee Health Science Center Institutional Review Board (#01-07346-XP). The proband and her parents were examined at the Center for Movement Disorders and Neurorestoration, Department of Neurology, University of Florida, and were part of the IRB approved INFORM clinical database. The proband&#x2019;s siblings live outside the United States and were unable to complete a study visit at the University of Florida. However, the siblings were interviewed via Skype (<ext-link ext-link-type="uri" xlink:href="http://www.skype.com">http://www.skype.com</ext-link>). Recruitment of neurologically-normal controls has been described previously [<xref ref-type="bibr" rid="B20">20</xref>].</p>
      <sec>
        <title>Identification of the duplication</title>
        <p>Clinical cytogenetic analyses were performed by Quest Diagnostics (Madison, NJ, USA) on DNA derived from whole blood using the Affymetrix Genome-Wide Human SNP Array 6.0. The Affymetrix 6.0 microarray contains over 1.8 million probes, including 900,000 copy number probes and 900,000 SNP probes. The average inter-probe distance is 700 base pairs. Thresholds for genome-wide screening were set at &gt;200&#xA0;kb for gains, &gt;50&#xA0;kb for losses and 10&#xA0;Mb for segments of homozygosity. A ~225&#xA0;kb gain of unclear clinical significance was detected in the proband at 13q34. Four genes were involved in the genomic alteration: <italic>ADPRHL1</italic>, <italic>DCUN1D2</italic>, <italic>TMCO3</italic> and <italic>TFDP1</italic>. Follow-up analyses of the parents using the same array indicated that the variant was of paternal origin. The classic <italic>TOR1A</italic> &#x394;GAG mutation was excluded with Sanger sequencing.</p>
        <p>For genomic breakpoint analysis and confirmation of copy numbers, DNA was extracted from peripheral blood leucocytes using Roche&#x2019;s DNA Isolation Kit for Mammalian Blood (Indianapolis, IN, USA). DNA quantity and quality were analyzed with a NanoDrop ND-1000 spectrophotometer (Wilmington, DE, USA) and agarose gel electrophoresis. Quantitative PCR (qPCR) primers and probes were designed via Roche&#x2019;s Universal Probe Library to encompass the estimated boundary regions (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>). qPCR was performed using 20&#xA0;ng of template DNA and 200 nM of each primer in a 10-&#x3BC;l reaction volume with the LightCycler&#x2122; 480 system and Universal Taqman&#xAE; probes (Roche). The following cycling conditions were employed: 95&#xB0;C for 5&#xA0;min; 45&#xA0;cycles at 95&#xB0;C for 10&#xA0;s, 60&#xB0;C for 30&#xA0;s, and 72&#xB0;C for 12&#xA0;s. Copy numbers were referenced to an endogenous control (<italic>RPPH1</italic>) and 9 neurologically-normal unrelated subjects. All assays were done in triplicate and means were used for comparisons. Long-range PCR was then performed using primers outside the boundary regions of the duplication (for example, Dup237_p13F and Dup025_p23R in Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>). After agarose gel purification, PCR products were sequenced in the forward and reverse directions on an Applied Biosystems 3130XL Genetic Analyzer (Carlsbad, CA, USA).</p>
        <p>Relative quantitative reverse-transcriptase PCR (QRT-PCR) was done to analyze the expression levels of genes located within or near the structural variant. In brief, Ambion&#x2019;s LeukoLOCK&#x2122; Total RNA Isolation System and TRI Reagent&#xAE; were used to isolate RNA from peripheral blood leukocytes. Leukocyte RNA was not available for the proband&#x2019;s siblings. Reverse transcription was performed with Ambion's RETROscript&#x2122; kit using 500&#xA0;ng total RNA as template along with random oligonucleotide primers. The reaction mixtures were incubated at 44&#xB0;C for 1&#xA0;hr and then at 92&#xB0;C for 10&#xA0;min. QRT-PCR was performed using the LightCycler<sup>TM</sup> 480 system with gene specific primers (Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>) and Universal Taqman&#xAE; probes (Roche) for 4 genes involved in the duplication region (<italic>ADPRHL1, DCUN1D2, TMCO3</italic>, and <italic>TFDP1</italic>)<italic>, TFDP1</italic> long non-coding RNA (lncRNA), 1 gene near the duplication (<italic>GRTP1</italic>), and the endogenous control (<italic>PPID</italic>), which encodes 40&#xA0;kDa peptidyl-prolyl cis-trans isomerase D (cyclophilin D). All assays were performed in triplicate and means were used for comparisons.</p>
        <p>Identification of exact breakpoints was facilitated by mapping flanking SNPs and Affymetrix copy number (CN) probes for the 13q34 duplication in both the proband and her father (bolded were predicted by Quest Diagnostics to be within the gain): SNP_A-1803536 (Chr13:114022946), CN_634194 (Chr13:114023445)<bold><italic>,</italic></bold> SNP_A-8304155 (Chr13:114023625), <bold>CN_091810(Chr13:114025424)</bold><bold><italic>, </italic></bold><bold>CN_634195(Chr13:114027458)</bold><bold><italic>, </italic></bold><bold>SNP_A-2261043(Chr13:114030927)</bold><bold><italic>, </italic></bold><bold>SNP_A-8505553(Chr13:114249807), CN_091834(Chr13:114249942)</bold>, CN_636300 (Chr13:114257699), and SNP_A-2105146(Chr13:114257910). With qPCR of genomic DNA we were able to confirm duplication of <italic>ADPRHL1</italic>, <italic>DCUN1D2</italic>, and <italic>TMCO3</italic>, and showed that <italic>GRTP1</italic> and <italic>TFDP1</italic> were, in fact, outside the duplicated segment (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref> and Table&#xA0;<xref ref-type="table" rid="T2">2</xref>). Fold changes of approximately 1.5&#xD7; for <italic>ADPRHL1</italic>, <italic>DCUN1D2</italic> and <italic>TMCO3</italic> were consistent with a duplication involving one allele of each gene. Stepwise long-range PCR and Sanger sequencing allowed us to identify the 5&#x2032; and 3&#x2032; breakpoints (Chr13:114,020,670 and Chr13:114,239,014) in the affected subject and her father (Figure&#xA0;<xref ref-type="fig" rid="F2">2</xref>). The duplicated segments were separated by a 69&#xA0;bp fragment. Nucleotide query with Basic Local Alignment Search Tool (BLAST) suggested that this 69&#xA0;bp fragment (Chr13:114,275,816-884) was duplicated from Intron 3 of <italic>TFDP1</italic>, 36&#xA0;kb 3&#x2032; to its location between the larger duplicated segment. A single deoxyadenosine (A) was detected 5&#x2032; to the smaller 69&#xA0;bp fragment. The 5&#x2032; breakpoint (Chr13:114,020,670) was located 3&#x2032; to the end of <italic>GRTP1</italic> (Chr13:114,018,463) and the 3&#x2032; breakpoint (Chr13:114,239,014) was located 5&#x2032; to the start of <italic>TFDP1</italic> (NM_007111.4: Chr13:114,239,056), within Exon 1 of a <italic>TFDP1</italic> long non-coding RNA (NR_026580.1). The 69&#xA0;bp fragment showed 100% sequence identity to a long terminal repeat (LTR) of the endogenous retrovirus family K (ERVK) located in Intron 3 of <italic>TFDP1</italic>. This LTR is 983 nt in length (Chr13:114,275,682-114,276,664). Collectively, the complex structural variant identified in our patient and her father can be denoted as <italic>NC_000013.10:g.114,020,670_114,239,014dup218,345;g.114,239,014_114,239,015ins(A&#x2009;+&#x2009;114,275,816_114,275,884).</italic> This variant was also identified in one of the proband&#x2019;s three brothers (Table&#xA0;<xref ref-type="table" rid="T3">3</xref>). It has not been reported in the Database of Genomic Variants (<ext-link ext-link-type="uri" xlink:href="http://projects.tcag.ca/variation/">http://projects.tcag.ca/variation/</ext-link>).</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Genomic rearrangement at 13q34.</bold> The 218,345&#xA0;bp duplication is shown beneath gene tracks adapted from the UCSC Genome Browser (GRCH37/hg19 Assembly). The nucleotide sequence for the 69&#xA0;bp fragment, possibly duplicated from an LTR located in Intron 3 of <italic>TFDP1</italic>, is shown in upper case red lettering.</p>
          </caption>
          <graphic xlink:href="1471-2350-14-70-2"/>
        </fig>
        <table-wrap position="float" id="T2">
          <label>Table 2</label>
          <caption>
            <p>Quantitative PCR of genomic DNA</p>
          </caption>
          <table frame="hsides" rules="groups" border="1">
            <colgroup>
              <col align="left"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="left" valign="bottom">
                  <bold>Primers</bold>
                  <hr/>
                </th>
                <th align="center" valign="bottom">
                  <bold>Location (13q34)</bold>
                  <hr/>
                </th>
                <th align="center" valign="bottom">
                  <bold>Normal controls</bold>
                  <hr/>
                </th>
                <th colspan="3" align="center" valign="bottom">
                  <bold>Subject fold change</bold>
                  <hr/>
                </th>
              </tr>
              <tr>
                <th align="left">&#xA0;</th>
                <th align="center">
                  <bold>NC_000013.10</bold>
                </th>
                <th align="center">
                  <bold>(N&#x2009;=&#x2009;9)</bold>
                </th>
                <th align="center">
                  <bold>Patient</bold>
                </th>
                <th align="center">
                  <bold>Father (carrier)</bold>
                </th>
                <th align="center">
                  <bold>Mother</bold>
                </th>
              </tr>
            </thead>
            <tbody valign="top">
              <tr>
                <td align="left" valign="bottom">Dup_018F/R<hr/></td>
                <td align="center" valign="bottom">114018980-9123<hr/></td>
                <td align="center" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.13<hr/></td>
                <td align="center" valign="bottom">0.94<hr/></td>
                <td align="center" valign="bottom">0.98<hr/></td>
                <td align="center" valign="bottom">1.01<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Dup_023F/R<hr/></td>
                <td align="center" valign="bottom">114023386-3429<hr/></td>
                <td align="center" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.15<hr/></td>
                <td align="center" valign="bottom">1.47<hr/></td>
                <td align="center" valign="bottom">1.51<hr/></td>
                <td align="center" valign="bottom">0.99<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Dup_025F/R<hr/></td>
                <td align="center" valign="bottom">114025267-5677<hr/></td>
                <td align="center" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.17<hr/></td>
                <td align="center" valign="bottom">1.52<hr/></td>
                <td align="center" valign="bottom">1.58<hr/></td>
                <td align="center" valign="bottom">1.02<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Dup_041F/R<hr/></td>
                <td align="center" valign="bottom">114041257-1333<hr/></td>
                <td align="center" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.12<hr/></td>
                <td align="center" valign="bottom">1.57<hr/></td>
                <td align="center" valign="bottom">1.49<hr/></td>
                <td align="center" valign="bottom">0.98<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Dup_228F/R<hr/></td>
                <td align="center" valign="bottom">114228694-8793<hr/></td>
                <td align="center" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.18<hr/></td>
                <td align="center" valign="bottom">1.61<hr/></td>
                <td align="center" valign="bottom">1.58<hr/></td>
                <td align="center" valign="bottom">1.08<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Dup_237F/R<hr/></td>
                <td align="center" valign="bottom">114237214-7282<hr/></td>
                <td align="center" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.09<hr/></td>
                <td align="center" valign="bottom">1.53<hr/></td>
                <td align="center" valign="bottom">1.55<hr/></td>
                <td align="center" valign="bottom">1.02<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Dup_241F/R<hr/></td>
                <td align="center" valign="bottom">114241291-1364<hr/></td>
                <td align="center" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.16<hr/></td>
                <td align="center" valign="bottom">0.95<hr/></td>
                <td align="center" valign="bottom">0.99<hr/></td>
                <td align="center" valign="bottom">0.98<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Dup_249F/R<hr/></td>
                <td align="center" valign="bottom">114249685-9762<hr/></td>
                <td align="center" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.10<hr/></td>
                <td align="center" valign="bottom">1.10<hr/></td>
                <td align="center" valign="bottom">1.04<hr/></td>
                <td align="center" valign="bottom">1.01<hr/></td>
              </tr>
              <tr>
                <td align="left">Dup_257F/R</td>
                <td align="center">114257807-7900</td>
                <td align="center">1.00&#x2009;&#xB1;&#x2009;0.11</td>
                <td align="center">1.08</td>
                <td align="center">0.99</td>
                <td align="center">1.00</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <table-wrap position="float" id="T3">
          <label>Table 3</label>
          <caption>
            <p>Pedigree genotypes</p>
          </caption>
          <table frame="hsides" rules="groups" border="1">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th rowspan="3" align="left" valign="top">
                  <bold>Family member</bold>
                </th>
                <th rowspan="3" align="left" valign="top">
                  <bold>Age</bold>
                </th>
                <th rowspan="3" align="left" valign="top">
                  <bold>Phenotype</bold>
                </th>
                <th rowspan="3" align="left" valign="top">
                  <bold>13q34 Duplication</bold>
                </th>
                <th rowspan="3" align="left" valign="top">
                  <bold>
                    <italic>SGCE </italic>
                  </bold>
                  <bold>Exon10</bold>
                </th>
                <th align="left" valign="bottom">
                  <bold>
                    <italic>BRCA1</italic>
                  </bold>
                  <bold>, rs799917</bold>
                  <hr/>
                </th>
                <th align="left" valign="bottom">
                  <bold>
                    <italic>XRCC3</italic>
                  </bold>
                  <bold>, rs861539</bold>
                  <hr/>
                </th>
              </tr>
              <tr>
                <th align="left" valign="bottom">
                  <bold>NC_000017:</bold>
                  <hr/>
                </th>
                <th align="left" valign="bottom">
                  <bold>NC_000014:</bold>
                  <hr/>
                </th>
              </tr>
              <tr>
                <th align="left">
                  <bold>g.41244936G&#x2009;&gt;&#x2009;A</bold>
                </th>
                <th align="left">
                  <bold>g.104165753G&#x2009;&gt;&#x2009;A</bold>
                </th>
              </tr>
            </thead>
            <tbody valign="top">
              <tr>
                <td align="left" valign="bottom">Proband<hr/></td>
                <td align="left" valign="bottom">37<hr/></td>
                <td align="left" valign="bottom">Generalized dystonia, breast cancer, dysmorphism<hr/></td>
                <td align="left" valign="bottom">Yes<hr/></td>
                <td align="left" valign="bottom">c.1294A&#x2009;&gt;&#x2009;C (homozygous), c.1295G&#x2009;&gt;&#x2009;A (heterozygous)<hr/></td>
                <td align="left" valign="bottom">heterozygous<hr/></td>
                <td align="left" valign="bottom">heterozygous<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Father<hr/></td>
                <td align="left" valign="bottom">71<hr/></td>
                <td align="left" valign="bottom">Normal<hr/></td>
                <td align="left" valign="bottom">Yes<hr/></td>
                <td align="left" valign="bottom">c.1294A&#x2009;&gt;&#x2009;C (homozygous), c.1295G&#x2009;&gt;&#x2009;A (heterozygous)<hr/></td>
                <td align="left" valign="bottom">heterozygous<hr/></td>
                <td align="left" valign="bottom">wild-type<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Mother<hr/></td>
                <td align="left" valign="bottom">70<hr/></td>
                <td align="left" valign="bottom">Normal<hr/></td>
                <td align="left" valign="bottom">No<hr/></td>
                <td align="left" valign="bottom">c.1294A&#x2009;&gt;&#x2009;C (homozygous)<hr/></td>
                <td align="left" valign="bottom">heterozygous<hr/></td>
                <td align="left" valign="bottom">heterozygous<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Brother<hr/></td>
                <td align="left" valign="bottom">47<hr/></td>
                <td align="left" valign="bottom">Normal<hr/></td>
                <td align="left" valign="bottom">No<hr/></td>
                <td align="left" valign="bottom">c.1294A&#x2009;&gt;&#x2009;C (homozygous)<hr/></td>
                <td align="left" valign="bottom">heterozygous<hr/></td>
                <td align="left" valign="bottom">wild-type<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Brother<hr/></td>
                <td align="left" valign="bottom">46<hr/></td>
                <td align="left" valign="bottom">Normal<hr/></td>
                <td align="left" valign="bottom">No<hr/></td>
                <td align="left" valign="bottom">c.1294A&#x2009;&gt;&#x2009;C (homozygous)<hr/></td>
                <td align="left" valign="bottom">heterozygous<hr/></td>
                <td align="left" valign="bottom">heterozygous<hr/></td>
              </tr>
              <tr>
                <td align="left">Brother</td>
                <td align="left">43</td>
                <td align="left">Normal</td>
                <td align="left">Yes</td>
                <td align="left">c.1294A&#x2009;&gt;&#x2009;C (homozygous), c.1295G&#x2009;&gt;&#x2009;A (heterozygous)</td>
                <td align="left">heterozygous</td>
                <td align="left">heterozygous</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Relative gene expression in leukocytes is shown in Table&#xA0;<xref ref-type="table" rid="T4">4</xref>. In the affected subject and her father, relative RNA expression was higher for all three genes located within the duplication region (<italic>ADPRHL1, DCUN1D2</italic> and <italic>TMCO3</italic>). However, in comparison to her mother and neurologically normal controls, the affected subject showed marked overexpression (&gt;2&#xD7;) of <italic>ADPRHL1</italic> and <italic>TMCO3</italic>. In contrast, gene expression in the father was approximately 0.5&#xD7; above control values for <italic>ADPRHL1</italic>, <italic>DCUN1D2</italic> and <italic>TMCO3</italic>, compatible with the presence of three copies of these genes. Of particular note, <italic>TFDP1</italic> and <italic>TFDP1</italic> lncRNA showed strong leukocyte overexpression in the affected subject but not in her father or mother. For gene expression analyses, all assays were performed in triplicate and means were used for comparisons.</p>
        <table-wrap position="float" id="T4">
          <label>Table 4</label>
          <caption>
            <p>Relative leukocyte gene expression</p>
          </caption>
          <table frame="hsides" rules="groups" border="1">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="left" valign="bottom">
                  <bold>Gene</bold>
                  <hr/>
                </th>
                <th rowspan="2" align="left" valign="top">
                  <bold>Location of the gene</bold>
                </th>
                <th align="left" valign="bottom">
                  <bold>Normal controls</bold>
                  <hr/>
                </th>
                <th colspan="3" align="center" valign="bottom">
                  <bold>Subject fold change</bold>
                  <hr/>
                </th>
              </tr>
              <tr>
                <th align="left">&#xA0;</th>
                <th align="left">
                  <bold>(N&#x2009;=&#x2009;9)</bold>
                </th>
                <th align="center">
                  <bold>Patient</bold>
                </th>
                <th align="center">
                  <bold>Father (carrier)</bold>
                </th>
                <th align="center">
                  <bold>Mother</bold>
                </th>
              </tr>
            </thead>
            <tbody valign="top">
              <tr>
                <td align="left" valign="bottom"><italic>ADPRHL1</italic> P1<hr/></td>
                <td rowspan="2" align="left" valign="top">Within duplication<hr/></td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.18<hr/></td>
                <td align="center" valign="bottom">2.71<hr/></td>
                <td align="center" valign="bottom">1.70<hr/></td>
                <td align="center" valign="bottom">1.10<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom"><italic>ADPRHL1</italic> P2<hr/></td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.25<hr/></td>
                <td align="center" valign="bottom">2.26<hr/></td>
                <td align="center" valign="bottom">1.70<hr/></td>
                <td align="center" valign="bottom">1.10<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom"><italic>DCUN1D2</italic> P1<hr/></td>
                <td rowspan="2" align="left" valign="top">Within duplication<hr/></td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.05<hr/></td>
                <td align="center" valign="bottom">1.48<hr/></td>
                <td align="center" valign="bottom">1.61<hr/></td>
                <td align="center" valign="bottom">0.95<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom"><italic>DCUN1D2</italic> P2<hr/></td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.19<hr/></td>
                <td align="center" valign="bottom">1.62<hr/></td>
                <td align="center" valign="bottom">1.46<hr/></td>
                <td align="center" valign="bottom">0.96<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom"><italic>TMCO3</italic> P1<hr/></td>
                <td rowspan="2" align="left" valign="top">Within duplication<hr/></td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.13<hr/></td>
                <td align="center" valign="bottom">3.13<hr/></td>
                <td align="center" valign="bottom">1.68<hr/></td>
                <td align="center" valign="bottom">1.04<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom"><italic>TMCO3</italic> P2<hr/></td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.06<hr/></td>
                <td align="center" valign="bottom">2.69<hr/></td>
                <td align="center" valign="bottom">1.59<hr/></td>
                <td align="center" valign="bottom">1.21<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom"><italic>TFDP1</italic> P1<hr/></td>
                <td rowspan="2" align="left" valign="top">3<italic>'</italic> to duplication<hr/></td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.20<hr/></td>
                <td align="center" valign="bottom">1.95<hr/></td>
                <td align="center" valign="bottom">1.05<hr/></td>
                <td align="center" valign="bottom">1.25<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">TFDP1 P2<hr/></td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.16<hr/></td>
                <td align="center" valign="bottom">2.04<hr/></td>
                <td align="center" valign="bottom">0.97<hr/></td>
                <td align="center" valign="bottom">1.18<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom"><italic>TFDP1</italic> lncRNA P1<hr/></td>
                <td rowspan="2" align="left" valign="top">3<italic>'</italic> to duplication<hr/></td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.18<hr/></td>
                <td align="center" valign="bottom">2.01<hr/></td>
                <td align="center" valign="bottom">0.93<hr/></td>
                <td align="center" valign="bottom">1.20<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom"><italic>TFDP1</italic> lncRNA P2<hr/></td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.21<hr/></td>
                <td align="center" valign="bottom">2.15<hr/></td>
                <td align="center" valign="bottom">0.95<hr/></td>
                <td align="center" valign="bottom">1.11<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom"><italic>GRTP1</italic> P1<hr/></td>
                <td rowspan="2" align="left" valign="top">5<italic>'</italic> to duplication</td>
                <td align="left" valign="bottom">1.00&#x2009;&#xB1;&#x2009;0.13<hr/></td>
                <td align="center" valign="bottom">1.08<hr/></td>
                <td align="center" valign="bottom">0.89<hr/></td>
                <td align="center" valign="bottom">1.26<hr/></td>
              </tr>
              <tr>
                <td align="left"><italic>GRTP1</italic> P2</td>
                <td align="left">1.00&#x2009;&#xB1;&#x2009;0.10</td>
                <td align="center">0.98</td>
                <td align="center">0.85</td>
                <td align="center">1.28</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec>
        <title>Exome sequencing and variant analysis</title>
        <p>To identify other genetic factors that could cause or contribute to risk of developing breast cancer and/or dystonia, in-solution whole-exome capture and massively parallel sequencing using the Agilent SureSelect XT All Exon Kit 51&#xA0;Mb (Santa Clara, CA, USA) was used to examine the proband&#x2019;s exome. Three micrograms of genomic DNA from the subject was sheared to yield 100&#x2013;450&#xA0;bp fragments. Sheared DNA was then subjected to Illumina paired-end library preparation followed by enrichment for target sequences (Agilent SureSelect<sup>XT</sup> Automated Target Enrichment for Illumina Paired-End Multiplexed Sequencing). Enriched DNA fragments were sequenced on Illumina&#x2019;s HiSeq 2000 platform as paired-end 100 base reads (Otogenetics Co., Norcross, GA, USA) and reads were mapped to the human reference genome with NextGENe&#xAE; (SoftGenetics, State College, PA, USA).</p>
        <p>Over 99.7% of exons were covered at &#x2265;2&#xD7; and 97.6% of exons were covered at &#x2265;20&#xD7;. To maximize the chances of detecting a pathogenic variant, base changes occurring in two or more reads were classified as variants for downstream analyses. We focused on genes associated with either breast cancer or dystonia (Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>). The pathogenicity of non-synonymous single amino acid substitutions was interrogated with six <italic>in silico</italic> tools: PolyPhen-2, MutationTaster, SIFT<sub>new</sub>, LRT<sub>new</sub> (Likelihood Ratio Test), PhyloP<sub>new</sub>, and ClustalW2 [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>]. Sequence variants in <italic>SGCE</italic>, <italic>BRCA1</italic>, and <italic>XRCC3</italic> were confirmed by Sanger sequencing in the forward and reverse directions. We identified a novel variant in <italic>SGCE</italic> (c.1295G&#x2009;&gt;&#x2009;A, p.Ser432His) that is unlikely to be pathogenic (Table&#xA0;<xref ref-type="table" rid="T3">3</xref>). Although predicted to be damaging by SIFT [<xref ref-type="bibr" rid="B24">24</xref>], p.Ser432His is poorly conserved [<xref ref-type="bibr" rid="B22">22</xref>] and classified as &#x201C;benign&#x201D; and &#x201C;polymorphism&#x201D; by Polyphen-2 [<xref ref-type="bibr" rid="B25">25</xref>] and MutationTaster [<xref ref-type="bibr" rid="B26">26</xref>], respectively. Whole exome sequencing also identified a <italic>CIZ1</italic> polymorphism that has not been associated with dystonia. Polymorphisms (dbSNP) were found in 16/25 breast cancer associated genes (Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>). Two of these (<italic>BRCA1</italic>, rs799917; and <italic>XRCC3</italic>, rs861539) have shown potential but inconclusive associations with breast cancer [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>].</p>
      </sec>
      <sec>
        <title>Discussion</title>
        <p>Dystonia is a neurological disorder characterized by involuntary sustained muscle contractions producing abnormal postures, twisting and repetitive abnormal movements, and sometimes painful muscle contractions. During dystonic movements, agonist and antagonist muscles co-contract in abnormal patterns. Dystonia is typically classified into primary, secondary, heredodegenerative diseases with dystonia, and dystonia-plus etiological categories [<xref ref-type="bibr" rid="B29">29</xref>]. Mutations in <italic>TOR1A</italic>, <italic>THAP1</italic>, <italic>CIZ1, ANO3, GNAL</italic> and <italic>TUBB4A</italic> have been associated with some cases of primary dystonia [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B30">30</xref>-<xref ref-type="bibr" rid="B33">33</xref>]. However, the genetic etiologies for most patients with primary dystonia remain unknown. The dystonia-plus category includes the myoclonus-dystonia syndrome (MDS) secondary to <italic>SGCE</italic> mutations. Nearly all affected individuals have myoclonus and 50 to 65% manifest dystonia, typically in the neck and arms. Depression and anxiety are important non-motor features of MDS. Although our proband did harbor a potentially pathogenic <italic>SGCE</italic> missense variant, other carriers in the pedigree were asymptomatic. Moreover, the anatomical distribution and onset age of the proband&#x2019;s dystonia were atypical for MDS.</p>
        <p>Secondary dystonia is caused by exogenous factors such as medications, toxins, or brain damage that may result from head trauma and stroke. Drugs that block dopamine receptors, such as neuroleptics and antiemetics, can cause acute dystonic reactions or late-onset, persistent &#x201C;tardive&#x201D; dystonia, after months or years of treatment [<xref ref-type="bibr" rid="B34">34</xref>]. Tardive movement disorders are usually hyperkinetic and include classic tardive oral-buccal-lingual dyskinesias and tardive chorea, dystonia, tics, tremor and akathisia. The differentiation of tardive from primary dystonia can be difficult and categorization remains clinical as it was for our patient. In this regard, it is quite uncommon for patients with tardive dystonia to progressively worsen months after discontinuation of drugs that block dopamine receptors. Although the genetic susceptibility for developing tardive movement disorders has been poorly characterized, sequence variants in genes associated with primary dystonia could be risk factors [<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>]. For instance, a novel missense mutation in <italic>TOR1A</italic> (c.613&#xA0;T&#x2009;&gt;&#x2009;A) has been linked to adult-onset lower facial and masticatory, possibly tardive, dystonia [<xref ref-type="bibr" rid="B35">35</xref>].</p>
        <p>It is now well-established that GPi DBS exerts beneficial effects on many dystonia subtypes [<xref ref-type="bibr" rid="B34">34</xref>-<xref ref-type="bibr" rid="B41">41</xref>]. In general, current experience with DBS suggests that primary dystonias respond better than most secondary dystonias [<xref ref-type="bibr" rid="B42">42</xref>]. However, many reports indicate that tardive dystonia can show significant improvements with DBS [<xref ref-type="bibr" rid="B42">42</xref>].</p>
        <p>The complex structural variant identified in our patient is of uncertain clinical significance since the three duplicated genes have not been associated with dystonia, intellectual disability or dysmorphism in human populations. Moreover, two clinically unaffected family members harbored the same variant. <italic>ADPRHL1</italic> encodes an ADP-ribosyltransferase that transfers ADP-ribose from NAD&#x2009;+&#x2009;to target proteins. <italic>DCUN1D2</italic> encodes a protein that may contribute to neddylation of cullin components of SCF-type E3 ubiquitin ligase complexes. Neddylation is the process by which <italic>NEDD8</italic> is conjugated to target proteins. <italic>NEDD8</italic> is an ubiquitin-like modifier of protein function. Finally, <italic>TMCO3</italic> encodes a transmembrane protein that probably functions as a Na<sup>+</sup>/H<sup>+</sup> antiporter. Chromosome 13q34 has, however, been linked to cancer, and, in Chinese, harbors a quantitative trait locus for physical height [<xref ref-type="bibr" rid="B43">43</xref>].</p>
        <p>Pathogenic structural variants can be inherited from normal parents [<xref ref-type="bibr" rid="B44">44</xref>-<xref ref-type="bibr" rid="B47">47</xref>]. Penetrance values have been calculated for some of the more common structural variants and, for example, can range from 10.4% for 15q11.2 deletions to 62.4% for distal 16p11.2 deletions [<xref ref-type="bibr" rid="B47">47</xref>]. Some structural variants may be associated with several phenotypes and penetrance is phenotype specific. Ultimately, other genetic and environmental factors contribute to penetrance and associated phenotypes. In the case of our proband, neuroleptic exposure may have increased her risk for breast cancer [<xref ref-type="bibr" rid="B48">48</xref>]. However, whole-exome sequencing did not expose pathogenic non-structural variants in genes associated with either breast cancer or dystonia.</p>
        <p>In our patient with dystonia and dysmorphism, it is possible that the presence of the breakpoint within the upstream promoter region of <italic>TFDP1</italic> (NM_007111.4) is responsible for altered expression of this transcription factor. The breakpoint could abrogate the effects of 5&#x2032; repressor regions on <italic>TFDP1</italic> expression. Over-expression of the <italic>TFDP1</italic> lncRNA could have also contributed to this effect since some lncRNAs have been shown to play important roles in transcriptional regulation [<xref ref-type="bibr" rid="B49">49</xref>]. In theory, the consequences of the breakpoint on <italic>TFDP1</italic> expression could be gender dependent. In this regard, <italic>TFDP1</italic> is part of the estrogen receptor ER&#x3B1; regulatory network [<xref ref-type="bibr" rid="B50">50</xref>]. Epistasis and epigenetics (DNA methylation or histone deacetylation) are additional mechanistic considerations [<xref ref-type="bibr" rid="B51">51</xref>] that could explain why the father and brother are asymptomatic carriers of the structural variant while the proband manifests dystonia due to overexpression of <italic>TFDP1</italic>. Conversely, <italic>TFDP1</italic> may have played no causal role in our patient&#x2019;s dystonia and other clinical manifestations.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>This is the first report to describe a potential connection between <italic>TFDP1</italic> and dystonia. Moreover, our analyses suggest that a <italic>TFDP1</italic> lncRNA (NR_026580.1) could play a role in regulating <italic>TFDP1</italic> expression. Our genetic findings are compatible with numerous previous studies which have consistently identified a link between chromosome 13q34 and cancer. Further studies in large case&#x2013;control cohorts will be needed to confirm possible associations between chromosome 13q34 and dystonia.</p>
      <sec>
        <title>Consent</title>
        <p>Written informed permission for use and disclosure of this families protected health information for research purposes and informed consent was obtained from the patient for publication of this case report and any accompanying images. Copies of the consents are available for review by the Editor-in-Chief of this journal.</p>
      </sec>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors&#x2019; contributions</title>
      <p>All authors reviewed the manuscript critically for its content, revised and edited it, and approved the final version. Additionally, specific author contributions are as follows: JX, GLR, SRV and MSL performed the genetic analyses; MM, RLR, KDF and MSO treated the patient and collected clinical data; MSL and MSO conceptualized, designed and coordinated the study; and MM, MSO and MSL generated the first draft of the manuscript. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/14/70/prepub">http://www.biomedcentral.com/1471-2350/14/70/prepub</ext-link>
      </p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material content-type="local-data" id="S1">
        <caption>
          <title>Additional file 1</title>
          <p>Primers used for PCR, QRT-PCR, qPCR, and Sanger sequencing.</p>
        </caption>
        <media xlink:href="1471-2350-14-70-S1.docx">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="S2">
        <caption>
          <title>Additional file 2</title>
          <p>Major genes associated with breast cancer.</p>
        </caption>
        <media xlink:href="1471-2350-14-70-S2.docx">
          <caption>
            <p>Click here for file</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgments</title>
      <p>The authors are grateful to the patient and her parents who made this report possible. At the University of Tennessee Health Science Center, this study was supported by the Neuroscience Institute (MSL), Tyler&#x2019;s Hope (MSL), Dystonia Medical Research Foundation (MSL), NIH grant R01NS069936 (MSL), and the NIH Dystonia Coalition Pilot Projects Program (U54NS065701). This study was supported by grants from Tyler's Hope for a Dystonia Cure.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Castillo</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Angulo</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Suarez-Gauthier</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Melchor</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Medina</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Sanchez-Verde</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Torres-Lanzas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pita</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Benitez</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sanchez-Cespedes</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Gene amplification of the transcription factor DP1 and CTNND1 in human lung cancer</article-title>
          <source>J Pathol</source>
          <year>2010</year>
          <volume>222</volume>
          <issue>1</issue>
          <fpage>89</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">20556744</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Diosdado</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Buffart</surname>
            <given-names>TE</given-names>
          </name>
          <name>
            <surname>Watkins</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Carvalho</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ylstra</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Tijssen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bolijn</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Lewis</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Maude</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Verbeke</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
          <article-title>High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas</article-title>
          <source>Clin Cancer Res</source>
          <year>2010</year>
          <volume>16</volume>
          <issue>5</issue>
          <fpage>1391</fpage>
          <lpage>1401</lpage>
          <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-09-1773</pub-id>
          <pub-id pub-id-type="pmid">20179237</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Yasui</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Arii</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Imoto</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ueda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nagai</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Emi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Inazawa</surname>
            <given-names>J</given-names>
          </name>
          <article-title>TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas</article-title>
          <source>Hepatol</source>
          <year>2002</year>
          <volume>35</volume>
          <issue>6</issue>
          <fpage>1476</fpage>
          <lpage>1484</lpage>
          <pub-id pub-id-type="doi">10.1053/jhep.2002.33683</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shinomiya</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mori</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ariyama</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sakabe</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Fukuda</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Murakami</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Inazawa</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon</article-title>
          <source>Genes Chromosomes Cancer</source>
          <year>1999</year>
          <volume>24</volume>
          <issue>4</issue>
          <fpage>337</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1098-2264(199904)24:4&lt;337::AID-GCC7&gt;3.0.CO;2-O</pub-id>
          <pub-id pub-id-type="pmid">10092132</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Abba</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Fabris</surname>
            <given-names>VT</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kittrell</surname>
            <given-names>FS</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>WW</given-names>
          </name>
          <name>
            <surname>Donehower</surname>
            <given-names>LA</given-names>
          </name>
          <name>
            <surname>Sahin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Medina</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Aldaz</surname>
            <given-names>CM</given-names>
          </name>
          <article-title>Identification of novel amplification gene targets in mouse and human breast cancer at a syntenic cluster mapping to mouse ch8A1 and human ch13q34</article-title>
          <source>Cancer Res</source>
          <year>2007</year>
          <volume>67</volume>
          <issue>9</issue>
          <fpage>4104</fpage>
          <lpage>4112</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-4672</pub-id>
          <pub-id pub-id-type="pmid">17483321</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Melchor</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Saucedo-Cuevas</surname>
            <given-names>LP</given-names>
          </name>
          <name>
            <surname>Munoz-Repeto</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Rodriguez-Pinilla</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Honrado</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Campoverde</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Palacios</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nathanson</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Garcia</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Benitez</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes</article-title>
          <source>Breast Cancer Res</source>
          <year>2009</year>
          <volume>11</volume>
          <issue>6</issue>
          <fpage>R86</fpage>
          <pub-id pub-id-type="doi">10.1186/bcr2456</pub-id>
          <pub-id pub-id-type="pmid">19995430</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lomazzi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Moroni</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Frittoli</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Helin</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry</article-title>
          <source>Nat Genet</source>
          <year>2002</year>
          <volume>31</volume>
          <issue>2</issue>
          <fpage>190</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="doi">10.1038/ng891</pub-id>
          <pub-id pub-id-type="pmid">11992123</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ravitz</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Wenner</surname>
            <given-names>CE</given-names>
          </name>
          <article-title>Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta</article-title>
          <source>Adv Cancer Res</source>
          <year>1997</year>
          <volume>71</volume>
          <fpage>165</fpage>
          <lpage>207</lpage>
          <pub-id pub-id-type="pmid">9111866</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Talluri</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Isaac</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Ahmad</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Henley</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Francis</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Martens</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Bremner</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Dick</surname>
            <given-names>FA</given-names>
          </name>
          <article-title>A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence</article-title>
          <source>Mol Cell Biol</source>
          <year>2010</year>
          <volume>30</volume>
          <issue>4</issue>
          <fpage>948</fpage>
          <lpage>960</lpage>
          <pub-id pub-id-type="doi">10.1128/MCB.01168-09</pub-id>
          <pub-id pub-id-type="pmid">20008551</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hoche</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Seidel</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Theis</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vlaho</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schubert</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zielen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kieslich</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Neurodegeneration in ataxia telangiectasia: what is new? What is evident?</article-title>
          <source>Neuropediatrics</source>
          <year>2012</year>
          <volume>43</volume>
          <issue>3</issue>
          <fpage>119</fpage>
          <lpage>129</lpage>
          <pub-id pub-id-type="pmid">22614068</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Saunders-Pullman</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Raymond</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Stoessl</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Hobson</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Nakamura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Pullman</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lefton</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Okun</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Uitti</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sachdev</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
          <article-title>Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites</article-title>
          <source>Neurol</source>
          <year>2012</year>
          <volume>78</volume>
          <issue>9</issue>
          <fpage>649</fpage>
          <lpage>657</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0b013e3182494d51</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Xiao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Uitti</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Vemula</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Perlmutter</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Wszolek</surname>
            <given-names>ZK</given-names>
          </name>
          <name>
            <surname>Maraganore</surname>
            <given-names>DM</given-names>
          </name>
          <name>
            <surname>Auburger</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Leube</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Lehnhoff</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
          <article-title>Mutations in CIZ1 cause adult onset primary cervical dystonia</article-title>
          <source>Ann Neurol</source>
          <year>2012</year>
          <volume>71</volume>
          <issue>4</issue>
          <fpage>458</fpage>
          <lpage>469</lpage>
          <pub-id pub-id-type="doi">10.1002/ana.23547</pub-id>
          <pub-id pub-id-type="pmid">22447717</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Swift</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lukin</surname>
            <given-names>JL</given-names>
          </name>
          <article-title>Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene</article-title>
          <source>Cancer Epidemiol Biomarkers Prev</source>
          <year>2008</year>
          <volume>17</volume>
          <issue>11</issue>
          <fpage>3188</fpage>
          <lpage>3192</lpage>
          <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-08-0414</pub-id>
          <pub-id pub-id-type="pmid">18990761</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cheng</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Lane</surname>
            <given-names>WS</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <article-title>ATM activates p53 by regulating MDM2 oligomerization and E3 processivity</article-title>
          <source>EMBO J</source>
          <year>2009</year>
          <volume>28</volume>
          <issue>24</issue>
          <fpage>3857</fpage>
          <lpage>3867</lpage>
          <pub-id pub-id-type="doi">10.1038/emboj.2009.294</pub-id>
          <pub-id pub-id-type="pmid">19816404</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Makino</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kaji</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ando</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tomizawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yasuno</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Goto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Matsumoto</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tabuena</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Maranon</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Dantes</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism</article-title>
          <source>Am J Hum Genet</source>
          <year>2007</year>
          <volume>80</volume>
          <issue>3</issue>
          <fpage>393</fpage>
          <lpage>406</lpage>
          <pub-id pub-id-type="doi">10.1086/512129</pub-id>
          <pub-id pub-id-type="pmid">17273961</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Li</surname>
            <given-names>HH</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Sheppard</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <article-title>Phosphorylation on Thr-55 by TAF1 mediates degradation of p53: a role for TAF1 in cell G1 progression</article-title>
          <source>Mol Cell</source>
          <year>2004</year>
          <volume>13</volume>
          <issue>6</issue>
          <fpage>867</fpage>
          <lpage>878</lpage>
          <pub-id pub-id-type="doi">10.1016/S1097-2765(04)00123-6</pub-id>
          <pub-id pub-id-type="pmid">15053879</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Coverley</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Marr</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ainscough</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Ciz1 promotes mammalian DNA replication</article-title>
          <source>J Cell Sci</source>
          <year>2005</year>
          <volume>118</volume>
          <issue>Pt 1</issue>
          <fpage>101</fpage>
          <lpage>112</lpage>
          <pub-id pub-id-type="pmid">15585571</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Koh</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Rehfeld</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ganetzky</surname>
            <given-names>B</given-names>
          </name>
          <article-title>A Drosophila model of early onset torsion dystonia suggests impairment in TGF-beta signaling</article-title>
          <source>Hum Mol Genet</source>
          <year>2004</year>
          <volume>13</volume>
          <issue>18</issue>
          <fpage>2019</fpage>
          <lpage>2030</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddh208</pub-id>
          <pub-id pub-id-type="pmid">15269177</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cayrol</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Lacroix</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Mathe</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ecochard</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Ceribelli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Loreau</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lazar</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Dessen</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Mantovani</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Aguilar</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
          <article-title>The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes</article-title>
          <source>Blood</source>
          <year>2007</year>
          <volume>109</volume>
          <issue>2</issue>
          <fpage>584</fpage>
          <lpage>594</lpage>
          <pub-id pub-id-type="doi">10.1182/blood-2006-03-012013</pub-id>
          <pub-id pub-id-type="pmid">17003378</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Xiao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Bastian</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Perlmutter</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Racette</surname>
            <given-names>BA</given-names>
          </name>
          <name>
            <surname>Tabbal</surname>
            <given-names>SD</given-names>
          </name>
          <name>
            <surname>Karimi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Paniello</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Wszolek</surname>
            <given-names>ZK</given-names>
          </name>
          <name>
            <surname>Uitti</surname>
            <given-names>RJ</given-names>
          </name>
          <etal/>
          <article-title>Novel THAP1 sequence variants in primary dystonia</article-title>
          <source>Neurol</source>
          <year>2010</year>
          <volume>74</volume>
          <issue>3</issue>
          <fpage>229</fpage>
          <lpage>238</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181ca00ca</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Jian</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Boerwinkle</surname>
            <given-names>E</given-names>
          </name>
          <article-title>dbNSFP: a lightweight database of human nonsynonymous SNPs and their functional predictions</article-title>
          <source>Hum Mutat</source>
          <year>2011</year>
          <volume>32</volume>
          <issue>8</issue>
          <fpage>894</fpage>
          <lpage>899</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.21517</pub-id>
          <pub-id pub-id-type="pmid">21520341</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Larkin</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Blackshields</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>NP</given-names>
          </name>
          <name>
            <surname>Chenna</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>McGettigan</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>McWilliam</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Valentin</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wallace</surname>
            <given-names>IM</given-names>
          </name>
          <name>
            <surname>Wilm</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lopez</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
          <article-title>Clustal W and Clustal X version 2.0</article-title>
          <source>Bioinformatics</source>
          <year>2007</year>
          <volume>23</volume>
          <issue>21</issue>
          <fpage>2947</fpage>
          <lpage>2948</lpage>
          <pub-id pub-id-type="doi">10.1093/bioinformatics/btm404</pub-id>
          <pub-id pub-id-type="pmid">17846036</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vemula</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Puschmann</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Rudzinska</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Frei</surname>
            <given-names>KP</given-names>
          </name>
          <name>
            <surname>Truong</surname>
            <given-names>DD</given-names>
          </name>
          <name>
            <surname>Wszolek</surname>
            <given-names>ZK</given-names>
          </name>
          <name>
            <surname>LeDoux</surname>
            <given-names>MS</given-names>
          </name>
          <article-title>Role of G&#x3B1;(olf) in familial and sporadic adult-onset primary dystonia</article-title>
          <source>Hum Mol Genet</source>
          <year>2013</year>
          <volume>22</volume>
          <issue>12</issue>
          <fpage>2510</fpage>
          <lpage>2519</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddt102</pub-id>
          <pub-id pub-id-type="pmid">23449625</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ng</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Henikoff</surname>
            <given-names>S</given-names>
          </name>
          <article-title>SIFT: Predicting amino acid changes that affect protein function</article-title>
          <source>Nucleic Acids Res</source>
          <year>2003</year>
          <volume>31</volume>
          <issue>13</issue>
          <fpage>3812</fpage>
          <lpage>3814</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id>
          <pub-id pub-id-type="pmid">12824425</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Adzhubei</surname>
            <given-names>IA</given-names>
          </name>
          <name>
            <surname>Schmidt</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Peshkin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ramensky</surname>
            <given-names>VE</given-names>
          </name>
          <name>
            <surname>Gerasimova</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bork</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Kondrashov</surname>
            <given-names>AS</given-names>
          </name>
          <name>
            <surname>Sunyaev</surname>
            <given-names>SR</given-names>
          </name>
          <article-title>A method and server for predicting damaging missense mutations</article-title>
          <source>Nat Methods</source>
          <year>2010</year>
          <volume>7</volume>
          <issue>4</issue>
          <fpage>248</fpage>
          <lpage>249</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>
          <pub-id pub-id-type="pmid">20354512</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Schwarz</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>R&#xF6;delsperger</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Schuelke</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Seelow</surname>
            <given-names>D</given-names>
          </name>
          <article-title>MutationTaster evaluates disease-causing potential of sequence alterations</article-title>
          <source>Nat Methods</source>
          <year>2010</year>
          <volume>7</volume>
          <issue>8</issue>
          <fpage>575</fpage>
          <lpage>576</lpage>
          <pub-id pub-id-type="doi">10.1038/nmeth0810-575</pub-id>
          <pub-id pub-id-type="pmid">20676075</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nicoloso</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Spizzo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wickramasinghe</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Shimizu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wojcik</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Ferdin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kunej</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
          <article-title>Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility</article-title>
          <source>Cancer Res</source>
          <year>2010</year>
          <volume>70</volume>
          <issue>7</issue>
          <fpage>2789</fpage>
          <lpage>2798</lpage>
          <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-3541</pub-id>
          <pub-id pub-id-type="pmid">20332227</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Silva</surname>
            <given-names>SN</given-names>
          </name>
          <name>
            <surname>Tomar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Paulo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gomes</surname>
            <given-names>BC</given-names>
          </name>
          <name>
            <surname>Azevedo</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Teixeira</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Pina</surname>
            <given-names>JE</given-names>
          </name>
          <name>
            <surname>Rueff</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gaspar</surname>
            <given-names>JF</given-names>
          </name>
          <article-title>Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51</article-title>
          <source>Cancer Epidemiol</source>
          <year>2010</year>
          <volume>34</volume>
          <issue>1</issue>
          <fpage>85</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1016/j.canep.2009.11.002</pub-id>
          <pub-id pub-id-type="pmid">20004634</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>LeDoux</surname>
            <given-names>MS</given-names>
          </name>
          <article-title>The genetics of dystonias</article-title>
          <source>Adv Genet</source>
          <year>2012</year>
          <volume>79</volume>
          <fpage>35</fpage>
          <lpage>85</lpage>
          <pub-id pub-id-type="pmid">22989765</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ozelius</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Hewett</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Page</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Bressman</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Kramer</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Shalish</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>de Leon</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Brin</surname>
            <given-names>MF</given-names>
          </name>
          <name>
            <surname>Raymond</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Corey</surname>
            <given-names>DP</given-names>
          </name>
          <etal/>
          <article-title>The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein</article-title>
          <source>Nat Genet</source>
          <year>1997</year>
          <volume>17</volume>
          <issue>1</issue>
          <fpage>40</fpage>
          <lpage>48</lpage>
          <pub-id pub-id-type="doi">10.1038/ng0997-40</pub-id>
          <pub-id pub-id-type="pmid">9288096</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Charlesworth</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Plagnol</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Holmstr&#xF6;m</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Bras</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sheerin</surname>
            <given-names>UM</given-names>
          </name>
          <name>
            <surname>Preza</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rubio-Agusti</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ryten</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Stamelou</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis</article-title>
          <source>Am J Hum Genet</source>
          <year>2012</year>
          <volume>91</volume>
          <issue>6</issue>
          <fpage>1041</fpage>
          <lpage>1050</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.10.024</pub-id>
          <pub-id pub-id-type="pmid">23200863</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fuchs</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Saunders-Pullman</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Masuho</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Luciano</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Raymond</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Factor</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lang</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>TW</given-names>
          </name>
          <name>
            <surname>Trosch</surname>
            <given-names>RM</given-names>
          </name>
          <etal/>
          <article-title>Mutations in GNAL cause primary torsion dystonia</article-title>
          <source>Nat Genet</source>
          <year>2013</year>
          <volume>45</volume>
          <issue>1</issue>
          <fpage>88</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">23222958</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="other">
          <name>
            <surname>Hersheson</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mencacci</surname>
            <given-names>NE</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Macdonald</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Trabzuni</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ryten</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pittman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Paudel</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kara</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Fawcett</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
          <article-title>Mutations in the autoregulatory domain of &#x3B2;-tubulin 4a cause hereditary dystonia</article-title>
          <source>Ann Neurol</source>
          <year>2012</year>
          <comment><bold>Dec 13</bold>. [Epub ahead of print] PubMed PMID: 23424103</comment>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Burke</surname>
            <given-names>RE</given-names>
          </name>
          <name>
            <surname>Fahn</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jankovic</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Marsden</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Lang</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Gollomp</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ilson</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs</article-title>
          <source>Neurol</source>
          <year>1982</year>
          <volume>32</volume>
          <issue>12</issue>
          <fpage>1335</fpage>
          <lpage>1346</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.32.12.1335</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Calakos</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>VD</given-names>
          </name>
          <name>
            <surname>Gottron</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tran-Viet</surname>
            <given-names>KN</given-names>
          </name>
          <name>
            <surname>Brewington</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Beyer</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Steffens</surname>
            <given-names>DC</given-names>
          </name>
          <name>
            <surname>Krishnan</surname>
            <given-names>RR</given-names>
          </name>
          <name>
            <surname>Zuchner</surname>
            <given-names>S</given-names>
          </name>
          <article-title>Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia</article-title>
          <source>J Med Genet</source>
          <year>2010</year>
          <volume>47</volume>
          <issue>9</issue>
          <fpage>646</fpage>
          <lpage>650</lpage>
          <pub-id pub-id-type="doi">10.1136/jmg.2009.072082</pub-id>
          <pub-id pub-id-type="pmid">19955557</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lee</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>SG</given-names>
          </name>
          <article-title>Genetics of tardive dyskinesia</article-title>
          <source>Int Rev Neurobiol</source>
          <year>2011</year>
          <volume>98</volume>
          <fpage>231</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">21907090</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cohen</surname>
            <given-names>OS</given-names>
          </name>
          <name>
            <surname>Hassin-Baer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Spiegelmann</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Deep brain stimulation of the internal globus pallidus for refractory tardive dystonia</article-title>
          <source>Parkinsonism Relat Disord</source>
          <year>2007</year>
          <volume>13</volume>
          <issue>8</issue>
          <fpage>541</fpage>
          <lpage>544</lpage>
          <pub-id pub-id-type="doi">10.1016/j.parkreldis.2006.11.007</pub-id>
          <pub-id pub-id-type="pmid">17236806</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Krauss</surname>
            <given-names>JK</given-names>
          </name>
          <article-title>Deep brain stimulation for dystonia in adults. Overview and developments</article-title>
          <source>Stereotact Funct Neurosurg</source>
          <year>2002</year>
          <volume>78</volume>
          <issue>3&#x2013;4</issue>
          <fpage>168</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="pmid">12652041</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Vidailhet</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vercueil</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Houeto</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Krystkowiak</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Benabid</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Cornu</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lagrange</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tezenas Du Montcel</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dormont</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Grand</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
          <article-title>Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>352</volume>
          <issue>5</issue>
          <fpage>459</fpage>
          <lpage>467</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa042187</pub-id>
          <pub-id pub-id-type="pmid">15689584</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kupsch</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Benecke</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Trottenberg</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>GH</given-names>
          </name>
          <name>
            <surname>Poewe</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Eisner</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wolters</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>JU</given-names>
          </name>
          <name>
            <surname>Deuschl</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
          <article-title>Pallidal deep-brain stimulation in primary generalized or segmental dystonia</article-title>
          <source>N Engl J Med</source>
          <year>2006</year>
          <volume>355</volume>
          <issue>19</issue>
          <fpage>1978</fpage>
          <lpage>1990</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa063618</pub-id>
          <pub-id pub-id-type="pmid">17093249</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Isaias</surname>
            <given-names>IU</given-names>
          </name>
          <name>
            <surname>Alterman</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Tagliati</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Outcome predictors of pallidal stimulation in patients with primary dystonia: the role of disease duration</article-title>
          <source>Brain</source>
          <year>2008</year>
          <volume>131</volume>
          <issue>Pt 7</issue>
          <fpage>1895</fpage>
          <lpage>1902</lpage>
          <pub-id pub-id-type="pmid">18567622</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tagliati</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shils</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Alterman</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Deep brain stimulation for dystonia</article-title>
          <source>Expert Rev Med Devices</source>
          <year>2004</year>
          <volume>1</volume>
          <issue>1</issue>
          <fpage>33</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="doi">10.1586/17434440.1.1.33</pub-id>
          <pub-id pub-id-type="pmid">16293008</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hong</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tsai</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Xing</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
          <article-title>A large-scale genome-wide linkage analysis to map loci linked to stature in Chinese population</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2008</year>
          <volume>93</volume>
          <issue>11</issue>
          <fpage>4511</fpage>
          <lpage>4518</lpage>
          <pub-id pub-id-type="doi">10.1210/jc.2008-0262</pub-id>
          <pub-id pub-id-type="pmid">18728177</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Mefford</surname>
            <given-names>HC</given-names>
          </name>
          <name>
            <surname>Sharp</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Baker</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Itsara</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Buysse</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Maloney</surname>
            <given-names>VK</given-names>
          </name>
          <name>
            <surname>Crolla</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Baralle</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
          <article-title>Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes</article-title>
          <source>N Engl J Med</source>
          <year>2008</year>
          <volume>359</volume>
          <issue>16</issue>
          <fpage>1685</fpage>
          <lpage>1699</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa0805384</pub-id>
          <pub-id pub-id-type="pmid">18784092</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Girirajan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Eichler</surname>
            <given-names>EE</given-names>
          </name>
          <article-title>Phenotypic variability and genetic susceptibility to genomic disorders</article-title>
          <source>Hum Mol Genet</source>
          <year>2010</year>
          <volume>19</volume>
          <issue>R2</issue>
          <fpage>R176</fpage>
          <lpage>R187</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/ddq366</pub-id>
          <pub-id pub-id-type="pmid">20807775</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Girirajan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Brkanac</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Coe</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Baker</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Vives</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Vu</surname>
            <given-names>TH</given-names>
          </name>
          <name>
            <surname>Shafer</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Bernier</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Ferrero</surname>
            <given-names>GB</given-names>
          </name>
          <name>
            <surname>Silengo</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Relative burden of large CNVs on a range of neurodevelopmental phenotypes</article-title>
          <source>PLoS Genet</source>
          <year>2011</year>
          <volume>7</volume>
          <issue>11</issue>
          <fpage>e1002334</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pgen.1002334</pub-id>
          <pub-id pub-id-type="pmid">22102821</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="other">
          <name>
            <surname>Rosenfeld</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Coe</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Eichler</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>Cuckle</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shaffer</surname>
            <given-names>LG</given-names>
          </name>
          <article-title>Estimates of penetrance for recurrent pathogenic copy-number variations</article-title>
          <source>Genet Med</source>
          <year>2012</year>
          <comment>Dec 20. [Epub ahead of print] PubMed PMID: 23258348</comment>
          <pub-id pub-id-type="doi">10.1038/gim.2012.164</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hippisley-Cox</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Vinogradova</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Coupland</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Parker</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case&#x2013;control study</article-title>
          <source>Arch Gen Psychiatry</source>
          <year>2007</year>
          <volume>64</volume>
          <issue>12</issue>
          <fpage>1368</fpage>
          <lpage>1376</lpage>
          <pub-id pub-id-type="doi">10.1001/archpsyc.64.12.1368</pub-id>
          <pub-id pub-id-type="pmid">18056544</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Chen</surname>
            <given-names>LL</given-names>
          </name>
          <name>
            <surname>Carmichael</surname>
            <given-names>GG</given-names>
          </name>
          <article-title>Decoding the function of nuclear long non-coding RNAs</article-title>
          <source>Curr Opin Cell Biol</source>
          <year>2010</year>
          <volume>22</volume>
          <issue>3</issue>
          <fpage>357</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ceb.2010.03.003</pub-id>
          <pub-id pub-id-type="pmid">20356723</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Shen</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Teng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Flockhart</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Skaar</surname>
            <given-names>TC</given-names>
          </name>
          <etal/>
          <article-title>A modulated empirical Bayes model for identifying topological and temporal estrogen receptor alpha regulatory networks in breast cancer</article-title>
          <source>BMC Syst Biol</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>67</fpage>
          <pub-id pub-id-type="doi">10.1186/1752-0509-5-67</pub-id>
          <pub-id pub-id-type="pmid">21554733</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tian</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Stamova</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Jickling</surname>
            <given-names>GC</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ander</surname>
            <given-names>BP</given-names>
          </name>
          <name>
            <surname>Bushnell</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>RR</given-names>
          </name>
          <name>
            <surname>Verro</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Pevec</surname>
            <given-names>WC</given-names>
          </name>
          <etal/>
          <article-title>Effects of gender on gene expression in the blood of ischemic stroke patients</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2012</year>
          <volume>32</volume>
          <issue>5</issue>
          <fpage>780</fpage>
          <lpage>791</lpage>
          <pub-id pub-id-type="doi">10.1038/jcbfm.2011.179</pub-id>
          <pub-id pub-id-type="pmid">22167233</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
